Pharma-Bio Serv (OTCMKTS:PBSV) Issues Quarterly Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSV) issued its quarterly earnings data on Monday. The company reported $0.01 earnings per share for the quarter, missing the consensus estimate of $0.03 by ($0.02), Zacks reports. The company had revenue of $2.70 billion for the quarter, compared to the consensus estimate of $2.70 billion. Pharma-Bio Serv had a return on equity of 0.55% and a net margin of 0.68%.

Pharma-Bio Serv Price Performance

PBSV opened at $0.57 on Wednesday. The stock’s 50 day moving average price is $0.53 and its 200-day moving average price is $0.54. Pharma-Bio Serv has a one year low of $0.43 and a one year high of $1.36.

Pharma-Bio Serv Company Profile

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc was founded in 1993 and is headquartered in Dorado, Puerto Rico.